Mitotic Checkpoint Inactivation Fosters Transformation in Cells Lacking the Breast Cancer Susceptibility Gene, Brca2
- 1 July 1999
- journal article
- research article
- Published by Elsevier in Molecular Cell
- Vol. 4 (1), 1-10
- https://doi.org/10.1016/s1097-2765(00)80182-3
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Casein Kinase II Catalyzes a Mitotic Phosphorylation on Threonine 1342 of Human DNA Topoisomerase IIα, Which Is Recognized by the 3F3/2 Phosphoepitope AntibodyPublished by Elsevier ,1998
- In vitro analysis of the dominant negative effect of p53 mutantsJournal of Molecular Biology, 1998
- Mutations of mitotic checkpoint genes in human cancersNature, 1998
- Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutationNature Genetics, 1997
- Double indemnity: p53, BRCA and cancerNature Medicine, 1997
- Human Rad51 Protein Promotes ATP-Dependent Homologous Pairing and Strand Transfer Reactions In VitroCell, 1996
- Dominant-negative p53 mutations selected in yeast hit cancer hot spots.Proceedings of the National Academy of Sciences, 1996
- Microinjection of mitotic cells with the 3F3/2 anti-phosphoepitope antibody delays the onset of anaphase.The Journal of cell biology, 1995
- A p53-Dependent Mouse Spindle CheckpointScience, 1995
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994